Drugs that contain Risedronate Sodium

1. Drug name - ACTONEL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7192938 APIL Method of treatment using bisphosphonic acid May, 2023

(7 months from now)

US7718634 APIL Method of treatment using bisphosphonic acid May, 2023

(7 months from now)

US7718634

(Pediatric)

APIL Method of treatment using bisphosphonic acid Nov, 2023

(1 year, 1 month from now)

US7192938

(Pediatric)

APIL Method of treatment using bisphosphonic acid Nov, 2023

(1 year, 1 month from now)

Treatment: Prevention and treatment of osteoporosis; Treatment of osteoporosis in postmenopausal women

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription
35MG TABLET;ORAL Prescription
75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET;ORAL Discontinued
150MG TABLET;ORAL Prescription

2. Drug name - ATELVIA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8246989 APIL Dosage forms of bisphosphonates Jan, 2026

(3 years from now)

US7645460 APIL Dosage forms of risedronate Jan, 2028

(5 years from now)

US7645459 APIL Dosage forms of bisphosphonates Jan, 2028

(5 years from now)

Treatment: Treatment of osteoporosis in postmenopausal women

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
35MG TABLET, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.